810528C

16:0 DNP Cap PE

1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[6-[(2,4-dinitrophenyl)amino]hexanoyl] (ammonium salt), chloroform

• Synonym(e): 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-[6-[(2,4-dinitrophenyl)amino]caproyl] (ammonium salt)
• Empirische Formel (Hill-System): C₄₉H₉₀N₅O₁₃P
• CAS-Nummer: 474943-10-7
• Molekulargewicht: 988.24
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 2.5 mL (810528C-25mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 810528C
• Konzentration: 10 mg/mL (810528C-25mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

Phosphoethanolamine is a precursor to phosphatidylcholine and phosphatidylethanolamine. 2,4-dinitrophenol (DNP) is a synthetic lipid-soluble compound which transports ions across the bioenergetic membranes.

Anwendung

16:0 DNP Cap PE may be used in Rho-PE-doped ink solution for the cell recruiting experiments. It may also be used to study its patterning conditions in order to pattern multiple species.

Biochem./physiol. Wirkung

Phosphoethanolamine participates in phospholipid metabolism. It has the ability to repress tumor growth both in vitro and in vivo.

Verpackung

5 mL Clear Glass Sealed Ampule (810528C-25mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system
• WGK: WGK 3